Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03181516Phase 2Completed
Phase 2, randomised, double-blind trial (2 arms), sponsored by Georgetown University. Primary endpoints: Number of Participants Experiencing Diarrhea at 14 days and Adverse Events at 180 days. Started Sep 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03181516.